Inhibition by sulfhydryl agents of arachidonic acid-induced platelet aggregation and release of potential inflammatory substances.
D000818:Animals; D001011:Aorta / Q000187:drug effects; D001095:Arachidonic Acids / Q000494:pharmacology*; D003300:Copper / Q000494:pharmacology; D003864:Depression, Chemical; D004229:Dithiothreitol / Q000494:pharmacology; D005990:Glycerol / Q000494:pharmacology; D066298:In Vitro Techniques; D007213:Indomethacin / Q000494:pharmacology; D008623:Mercaptoethanol / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects; D009638:Norepinephrine / Q000494:pharmacology; D010396:Penicillamine / Q000494:pharmacology; D010973:Platelet Adhesiveness / Q000187:drug effects*; D010974:Platelet Aggregation / Q000187:drug effects*; D011453:Prostaglandins / Q000494:pharmacology; D011748:Pyrogallol / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D013268:Stimulation, Chemical; D013270:Stomach / Q000187:drug effects; D013439:Sulfhydryl Reagents / Q000494:pharmacology*; D013859:Thiocarbamates / Q000494:pharmacology
D001095:Arachidonic Acids; D011453:Prostaglandins; D013439:Sulfhydryl Reagents; D013859:Thiocarbamates; D011748:Pyrogallol; D008623:Mercaptoethanol; D003300:Copper; D010396:Penicillamine; D005990:Glycerol; D004229:Dithiothreitol; D009638:Norepinephrine; D007213:Indomethacin